Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CI
CI logo

CI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
263.550
Open
262.410
VWAP
260.85
Vol
2.06M
Mkt Cap
68.75B
Low
258.140
Amount
536.84M
EV/EBITDA(TTM)
6.96
Total Shares
263.53M
EV
92.05B
EV/OCF(TTM)
9.59
P/S(TTM)
0.26
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Show More

Events Timeline

(ET)
2026-03-03
16:20:00
US Stocks Drop Amid Middle East Tensions; Trump Announces Maritime Trade Security Measures
select
2026-03-03
11:50:00
Middle East Conflict Escalates, Major Indices Down Nearly 1.5%
select
2026-03-03
10:30:00
JPMorgan Maintains Overweight Rating on Cigna
select
2026-03-03
10:20:00
Barclays Calls Cigna's New CEO Evanko a Natural Successor
select
2026-03-03
07:40:00
Company Reaffirms 2026 Adjusted Income of At Least $30.25 Per Share
select
2026-03-03
07:40:00
Cigna Group CEO David Cordani to Retire
select
2026-02-18 (ET)
2026-02-18
07:40:00
BrainsWay Comments on Evernorth's Elimination of TMS Prior Authorization
select

News

Barron's
4.5
03-06Barron's
Challenging Stock Market Conditions, Yet These 5 Funds Are Thriving.
  • Positive Market News: Despite recent negative headlines regarding Iran, oil prices, market losses, and poor job numbers, there is encouraging news in the financial sector.

  • High-Performing Funds: Five investment funds are currently performing exceptionally well, providing a bright spot in an otherwise challenging economic landscape.

seekingalpha
4.0
03-05seekingalpha
Analysis of Current U.S. Labor Market Conditions
  • Job Growth Expectations: February's nonfarm payrolls are projected to increase by approximately 60,000, down from 130,000 in January, indicating moderate growth in the labor market, though it fails to inspire strong economic confidence.
  • Unemployment Rate Increase: The unemployment rate is expected to rise to 4.4% from 4.3% last month, reflecting signs of weakening consumer spending that could negatively impact economic growth.
  • Weakening Consumer Spending: Real personal consumption expenditures have slowed to a year-over-year growth rate of 1.7%, about half of the long-term average, indicating a decline in consumer confidence that may affect future economic activity.
  • Industry Dynamics Observation: While job growth in healthcare and social services continues, layoffs in the tech sector raise concerns, particularly regarding job shifts related to artificial intelligence, which may impact the overall structure of the labor market.
CNBC
8.5
03-05CNBC
Eli Lilly Launches New Program to Enhance Obesity Drug Coverage
  • Program Launch: Eli Lilly has introduced the 'Employer Connect' platform aimed at helping more employers cover obesity drugs, addressing a major barrier to patient access and expected to enhance employee drug accessibility.
  • Price Transparency: Through this platform, employers can purchase a multi-dose form of Zepbound at a net discounted price of $449 per month, avoiding traditional rebate models, thereby providing clearer visibility on drug pricing for employers.
  • Flexible Benefits Design: Employers can choose from 15 different third-party administrators to design benefits tailored to their budget and workforce needs, offering comprehensive obesity management services including telehealth, nutrition, and lifestyle support.
  • Government Insurance Coverage: Under landmark deals with President Trump, Medicare will cover obesity drugs for the first time, which is expected to further expand drug accessibility and benefit more patients.
Newsfilter
6.5
03-04Newsfilter
Cigna Group's Financial Ratings Affirmed by AM Best
  • Financial Strength Rating: AM Best has affirmed Cigna Group's Financial Strength Rating at A (Excellent) and Long-Term Issuer Credit Ratings at 'a+' (Excellent), reflecting its robust balance sheet and stable operating performance, which is expected to enhance investor confidence.
  • Capital Adequacy Advantage: Cigna Life & Health Group's risk-adjusted capitalization is assessed at the highest level, and despite a financial leverage exceeding 43%, strong profitability and liquidity support its debt servicing capacity, ensuring future financial flexibility.
  • Revenue Diversification: Cigna's revenue is geographically diversified, primarily from its commercial health insurance business in the U.S., and while the anticipated sale of its Medicare and CareAllies businesses in 2025 may decrease overall revenues, growth in cash flow is expected from its non-insurance operations through Evernorth Health Services.
  • Mature Risk Management: Cigna has implemented a comprehensive Enterprise Risk Management (ERM) program that integrates risk management with strategic planning across business units, further enhancing the company's operational stability and market competitiveness.
Businesswire
6.0
03-04Businesswire
Cigna Group's Financial Ratings Affirmed by AM Best
  • Financial Strength Rating Affirmed: AM Best has affirmed Cigna Group's Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of “a+” (Excellent), reflecting its strong balance sheet and operating performance, which is expected to bolster investor confidence.
  • Strong Capital Adequacy: Cigna Life & Health Group maintains the highest level of risk-adjusted capitalization as measured by Best’s Capital Adequacy Ratio (BCAR), and despite an elevated financial leverage of over 43%, its robust earnings and liquidity support its debt servicing capacity, ensuring financial flexibility.
  • Revenue Diversification: Cigna's revenues are geographically diversified, primarily from the U.S. market, although the anticipated sale of its Medicare and CareAllies businesses in 2025 is expected to decrease overall revenues, its core commercial health products continue to maintain a strong market presence.
  • Mature Risk Management: Cigna has implemented a comprehensive Enterprise Risk Management (ERM) program integrated into daily operations and strategic planning, ensuring stable operational performance and risk control capabilities in a complex market environment.
seekingalpha
4.0
03-04seekingalpha
Rising Health Insurance Costs Drag Wage Growth by 20%
  • Wage Growth Constraints: The Federal Reserve Bank of New York estimated that rising employee health insurance costs, driven by GLP-1 obesity drugs and other factors, dragged wage growth down by as much as 20% last year, significantly impacting corporate compensation strategies.
  • Projected Wage Increases: The research indicated that had health insurance costs not risen, businesses could have offered an average wage increase of approximately 4.7% in 2025, while the actual average wage increase was only 3.8%, highlighting the direct impact of cost pressures on wage policies.
  • Rising Insurance Costs: The Kaiser Family Foundation estimated a 6% rise in health insurance costs for 2025, with the Fed survey confirming a 13% increase, reflecting the pressure of soaring healthcare expenditures on corporate operations.
  • Corporate Response Strategies: Although not all firms provide health insurance, the study suggests that rising costs are increasing cost pressures for some businesses, thereby limiting wage growth for many workers and affecting overall economic vitality.
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
Wall Street analysts forecast CI stock price to rise
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Piper Sandler
Overweight
maintain
$374 -> $370
AI Analysis
2026-03-03
Reason
Piper Sandler
Price Target
$374 -> $370
AI Analysis
2026-03-03
maintain
Overweight
Reason
Piper Sandler lowered the firm's price target on Cigna to $370 from $374 and keeps an Overweight rating on the shares. The company's pioneering rebate-free PBS model will help Cigna comply with the 2026 CAA, meet the terms of its FTC settlement, and reshape public perception of PBMs, the firm says. These efforts derisk the long-term PBS growth algorithm and deserve multiple expansion, in Piper's view.
Truist
Buy
maintain
$320 -> $350
2026-02-17
Reason
Truist
Price Target
$320 -> $350
2026-02-17
maintain
Buy
Reason
Truist raised the firm's price target on Cigna to $350 from $320 and keeps a Buy rating on the shares. The firm is adjusting its model after the company's Q4 results and 2026 guidance, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cigna Group (CI.N) is 9.14, compared to its 5-year average forward P/E of 10.86. For a more detailed relative valuation and DCF analysis to assess Cigna Group's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.86
Current PE
9.14
Overvalued PE
12.00
Undervalued PE
9.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.02
Current EV/EBITDA
7.97
Overvalued EV/EBITDA
9.85
Undervalued EV/EBITDA
8.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.40
Current PS
0.26
Overvalued PS
0.47
Undervalued PS
0.34

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what stock should i buy right now
Intellectia · 55 candidates
Quarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Is Index Component: GSPCMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
MU logo
MU
Micron Technology Inc
473.78B
MS logo
MS
Morgan Stanley
279.54B
TMUS logo
TMUS
T-Mobile US Inc
234.97B
NEE logo
NEE
Nextera Energy Inc
190.06B
BLK logo
BLK
BlackRock Inc
177.82B
DE logo
DE
Deere & Co
160.82B
name me one concrete stock to buy
Intellectia · 28 candidates
Market Cap: >= 10.00BRegion: USQuarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Is Index Component: GSPCOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
DE logo
DE
Deere & Co
163.44B
FE logo
FE
FirstEnergy Corp
28.94B
CTRA logo
CTRA
Coterra Energy Inc
23.80B
MPWR logo
MPWR
Monolithic Power Systems Inc
57.06B
PKG logo
PKG
Packaging Corp of America
22.16B
HUBB logo
HUBB
Hubbell Inc
27.86B
stocks to look into tmr
Intellectia · 9 candidates
Relative Vol: >= 2Is Index Component: GSPCOne Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 5,000,000
Ticker
Name
Market Cap$
top bottom
WAB logo
WAB
Westinghouse Air Brake Technologies Corp
41.66B
ROK logo
ROK
Rockwell Automation Inc
47.41B
EBAY logo
EBAY
eBay Inc
39.08B
IR logo
IR
Ingersoll Rand Inc
38.97B
KKR logo
KKR
KKR & Co Inc
91.54B
EXPE logo
EXPE
Expedia Group Inc
28.41B
which stocks should I buy?
Intellectia · 68 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Can you add a screener for me?A I
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
insiders buying in last 30 days
Intellectia · 505 candidates
Insider Transactions: NetPurchase
Ticker
Name
Market Cap$
top bottom
GE logo
GE
General Electric Co
335.96B
LIN logo
LIN
Linde PLC
205.15B
SPGI logo
SPGI
S&P Global Inc
160.84B
ETN logo
ETN
Eaton Corporation PLC
131.26B
SBUX logo
SBUX
Starbucks Corp
109.65B
NKE logo
NKE
Nike Inc
96.83B
select 5 stocks with strong buy rating
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B
¿Qué acción debería invertir sí o si
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
what is a good thing to in vest in now
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
which stocks are strong buys
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B

Whales Holding CI

S
SAMA Foreign Holdings
Holding
CI
+17.03%
3M Return
G
GQG Partners, LLC
Holding
CI
+16.20%
3M Return
M
Mubadala Investment Company PJSC
Holding
CI
+12.81%
3M Return
C
Conning, Inc.
Holding
CI
+9.61%
3M Return
G
Greenwich Wealth Management, LLC
Holding
CI
+7.39%
3M Return
D
Distillate Capital Partners LLC
Holding
CI
+4.79%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cigna Group (CI) stock price today?

The current price of CI is 260.87 USD — it has decreased -0.6

What is Cigna Group (CI)'s business?

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

What is the price predicton of CI Stock?

Wall Street analysts forecast CI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cigna Group (CI)'s revenue for the last quarter?

Cigna Group revenue for the last quarter amounts to 72.47B USD, increased 10.39

What is Cigna Group (CI)'s earnings per share (EPS) for the last quarter?

Cigna Group. EPS for the last quarter amounts to 4.55 USD, decreased -11.31

How many employees does Cigna Group (CI). have?

Cigna Group (CI) has 67700 emplpoyees as of March 12 2026.

What is Cigna Group (CI) market cap?

Today CI has the market capitalization of 68.75B USD.